Heart infection vegetation removal with a tube
Part of Heart & circulation clinical trials.
This study tests a procedure to remove infected growths (vegetations) from the right side of the heart using a tube inserted through a vein. It may be an option for people with a serious heart infection who need the vegetation removed without open-heart surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a heart infection (infective endocarditis) on your own heart valves.
- You have a vegetation (infected growth) on the right side of your heart that is larger than 1 cm.
- You do not have a serious illness that would make the procedure too risky.
- You have not had a stroke in the last 3 months, and you do not have a bleeding disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people who have heart surgery to treat a serious heart infection called infective endocarditis. It helps doctors learn more about how these surgeries work and what affects recovery.
This study collects information from patients who have had a procedure called AngioVac aspiration to remove blood clots or infected material from the heart or blood vessels. It aims to learn more about how well this treatment works and its safety by reviewing medical records.
This study tests whether removing certain inflammation signals (cytokines) can help people with severe heart infection (infective endocarditis) who are having heart surgery soon. It may help reduce harmful inflammation around the time of surgery, but it also has several medication and health-condition requirements.
This study tests whether an FDG-PET/CT scan (a special imaging test) can help doctors choose the best treatment plan for people with a suspected native heart valve infection. It may help reduce uncertainty by showing where the infection activity is.
This trial compares removing a heart device (like a pacemaker) versus using antibiotics and other medical care to treat an infection. It may help doctors decide the best way to handle infections related to these devices.
This trial tests if adding bacteriophages (viruses that kill bacteria) to standard antibiotic treatment can help people with a serious heart valve infection called infective endocarditis. It may offer a new way to fight the infection.
Hear when a new Infective Endocarditis (IE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.